Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending September 20, 2020 Late-onset neutropenia more common than expected in patients on rituximab, Biologics for psoriasis may also reduce coronary plaque, Trabecular bone loss may contribute to axial spondyloarthritis progression, Diffuse idiopathic skeletal hyperostosis heart risk higher than expected, COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate, More must reads Must reads for theWeek ending September 13, 2020 Social distancing impacts other infectious diseases, High disability after a year of RA treatment signals increased mortality risk, MIS-C cardiac evaluation requires more than EF, Study: 10% of pregnant women test positive for COVID-19, with most asymptomatic, Respiratory disease raises rheumatoid arthritis risk in nonsmokers, More must readsMust reads for theWeek ending September 6, 2020 Phone outreach intervention feasible to reduce SLE readmissions, Asymptomatic children may transmit COVID-19 in communities, CagA-positive H. pylori patients at higher risk of osteoporosis, fracture, More must readsMust reads for theWeek ending August 30, 2020 SARS-CoV-2 appears unlikely to pass through breast milk, Researchers home in on optimal biopsy length for giant cell arteritis, More must readsMust reads for theWeek ending August 23, 2020 Age, smoking among leading cancer risk factors for SLE patients, Canakinumab (Ilaris) tapering tested in systemic JIA trial, SGLT2 inhibitors with metformin look safe for bone, Obesity negatively affects axial spondyloarthritis disease activity, The evidence is not clear: Rheumatic diseases, drugs, and COVID-19, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 last »
